Literature DB >> 8005256

Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD.

R E Wegner1, R A Jörres, D K Kirsten, H Magnussen.   

Abstract

In this study we aimed to determine the relationship between exercise capacity, clinical ratings of dyspnoea and lung function parameters in patients with severe chronic obstructive pulmonary disease (COPD) by means of the statistical method of factor analysis. Sixty two patients (mean age +/- SD, 66 +/- 9 yrs) in stable clinical condition, with a forced expiratory volume in one second (FEV1) < 65% of predicted were investigated. Before the study, therapy was optimized, including inhaled bronchodilators, theophylline and steroids. Exercise capacity was determined from the best 6 min walking distance achieved in five self-paced treadmill walks performed on consecutive days. Lung function testing comprised spirometry and body plethysmography. Four different tools were chosen to rate dyspnoea and quality of life: the Baseline Dyspnoea Index (BDI), the Oxygen Cost Diagram (OCD), a modified Medical Research Council (MRC) Scale, and the Chronic Respiratory Disease Questionnaire (CRQ). Principal component factor analysis revealed that the data could be reduced to three hypothetical underlying variables (factors), which accounted for 79% of the total variance. BDI, MRC, OCD, CRQ and walking distance were attributed to the first factor, forced expiratory volume in one second and airway resistance to the second factor, and lung volumes to the third factor. Thus, our data suggest that the pathophysiological condition of severe COPD is characterized by three statistically independent entities: 1) exercise capacity, dyspnoea and quality of life ratings; 2) airway obstruction; and 3) pulmonary hyperinflation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8005256     DOI: 10.1183/09031936.94.07040725

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  23 in total

1.  Rehabilitation for people with chronic lung disease.

Authors:  M D Morgan; F H Quirk; S J Singh
Journal:  Qual Health Care       Date:  1995-12

2.  Patients' self-reports of dyspnea: An important and independent outcome in chronic obstructive pulmonary disease.

Authors:  E G Eakin; R M Kaplan; A L Ries; D E Sassi-Dambron
Journal:  Ann Behav Med       Date:  1996-06

Review 3.  Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.

Authors:  B Jarvis; A Markham
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 4.  Exercise and cystic fibrosis.

Authors:  A K Webb; M E Dodd; J Moorcroft
Journal:  J R Soc Med       Date:  1995       Impact factor: 5.344

5.  Natural histories of chronic obstructive pulmonary disease.

Authors:  Stephen I Rennard; Jørgen Vestbo
Journal:  Proc Am Thorac Soc       Date:  2008-12-15

6.  Home-based pulmonary rehabilitation program: Effect on exercise tolerance and quality of life in chronic obstructive pulmonary disease patients.

Authors:  Maha Ghanem; Enace Abd Elaal; Mogedda Mehany; Kawthar Tolba
Journal:  Ann Thorac Med       Date:  2010-01       Impact factor: 2.219

7.  Patient-reported dyspnea in COPD reliability and association with stage of disease.

Authors:  Donald A Mahler; Joseph Ward; Laurie A Waterman; Corliss McCusker; Richard ZuWallack; John C Baird
Journal:  Chest       Date:  2009-08-20       Impact factor: 9.410

8.  Factor analysis reveals differences in brain metabolism in macaques with SIV/AIDS and those with SIV-induced encephalitis.

Authors:  Margaret R Lentz; Vallent Lee; Susan V Westmoreland; Eva-Maria Ratai; Elkan F Halpern; R Gilberto González
Journal:  NMR Biomed       Date:  2008-10       Impact factor: 4.044

9.  Risk factors of readmission to hospital for a COPD exacerbation: a prospective study.

Authors:  J Garcia-Aymerich; E Farrero; M A Félez; J Izquierdo; R M Marrades; J M Antó
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

10.  Evaluation of three scales of dyspnea in chronic obstructive pulmonary disease.

Authors:  S K Chhabra; A K Gupta; M Z Khuma
Journal:  Ann Thorac Med       Date:  2009-07       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.